# Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

> **NCT04846010** · PHASE1,PHASE2 · UNKNOWN · sponsor: **All Natural Medicine Clinic, LLC** · enrollment: 2000 (estimated)

## Conditions studied

- Sequelae of; Infection
- Post Infection Glomerulonephritis
- Post-Infectious Peripheral Neuralgia
- Post-Infectious Disorder (Disorder)
- Post-Infectious Arthritis
- Post-Infectious Polyneuritis
- Post-Infectious Parkinsonism
- Post-Infectious Hypothyroidism
- Post Infectious Osteoarthritis
- Anxiety Disorders
- Depression
- Depression, Anxiety
- Depression, Bipolar
- Insomnia
- GERD
- Gastro Esophageal Reflux
- Hepatitis
- Glomerulonephritis

## Interventions

- **COMBINATION_PRODUCT:** PurWet
- **COMBINATION_PRODUCT:** FurFat
- **COMBINATION_PRODUCT:** PurApo
- **COMBINATION_PRODUCT:** PurPhl
- **COMBINATION_PRODUCT:** PurClo
- **COMBINATION_PRODUCT:** PurInf
- **COMBINATION_PRODUCT:** Smoliv

## Key facts

- **NCT ID:** NCT04846010
- **Lead sponsor:** All Natural Medicine Clinic, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2021-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04846010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04846010, "Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04846010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*